Skip to main content
main-content

Diabetes complications and comorbidities

Macular edema

07-09-2018 | Retinopathy | Article

Global perspectives on the provision of diabetic retinopathy screening and treatment: Survey of health care professionals in 41 countries

Cavan D et al. Diabetes Res Clin Prac 2018; 143: 170–178. doi: 10.1016/j.diabres.2018.07.004

06-30-2018 | Metformin | Review | Article

Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy

van Stee MF, de Graaf AA, Groen AK. Cardiovasc Diabetol 2018; 17: 94. doi: 10.1186/s12933-018-0738-4

06-19-2018 | Retinopathy | Review | Article

New insights into diabetic retinopathy by OCT angiography

Liu G, Xu D, Wang F. Diabetes Res Clin Prac 2018; 142: 243–253. doi: 10.1016/j.diabres.2018.05.043

03-07-2018 | Retinopathy | News

News in brief

Light mask ruled out for preventing early diabetic macular edema progression

The CLEOPATRA trial results show that wearing a mask that emits blue–green light during sleep does not reduce the progression of non-central diabetic macular edema.

08-22-2017 | Retinopathy | Editorial | Article

Antivascular endothelial growth factor treatment for proliferative diabetic retinopathy: Perspective on the CLARITY study

In this editorial, Rishi Singh and colleagues provide their perspective on the future of proliferative diabetic retinopathy treatment following the completion of the CLARITY and Protocol S studies.

Authors:
Nathaniel B. Rieveschl, Felipe F. Conti, Rishi P. Singh

07-04-2017 | Complications | News

June Cochrane review round-up

Here we provide an overview of the seven Cochrane reviews published in June that covered topics relating to diabetes, including glycemic control for prevention of renal failure, phototherapy for foot ulcers, and anti-vascular endothelial growth factor treatment for diabetic macular edema.

Source:

Cochrane Database Syst Rev 2017; 6: CD010137, CD007419, CD009613, CD011979, CD011038

05-31-2017 | Macular edema | Review | Article

Action on diabetic macular edema: Achieving optimal patient management in treating visual impairment due to diabetic eye disease

Eye 2017; 31: S1–S20. doi: 10.1038/eye.2017.53

Authors:
R Gale, P H Scanlon, M Evans, F Ghanchi, y Yang, G Silvestri, M Freeman, A Maisey, J Napier

05-12-2017 | Aflibercept | News

Aflibercept has edge over laser retinopathy treatment in CLARITY trial

Results of the CLARITY trial suggest that aflibercept treatment may produce better visual outcomes than laser photocoagulation in patients with proliferative diabetic retinopathy.

Source:

Lancet 2017; Advance online publication

04-28-2017 | Retinopathy | Article

Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema

Eye 2017; 31: 1358–1364. doi: 10.1038/eye.2017.69

Authors:
L Nicholson, N V Patrao, J Ramu, C Vazquez-Alfageme, M Muwas, R Rajendram, P G Hykin, S Sivaprasad

02-25-2017 | Macular edema | Article

Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema

Bahrami B et al. Graefes Arch Clin Exp Ophthalmol 2017; 255: 1133–1140. doi: 10.1007/s00417-017-3624-y

02-14-2017 | Macular edema | Review | Article

Therapeutic options in refractory diabetic macular edema

Shah SU, Maturi RK. Drugs 2017; 77: 481–492. doi: 10.1007/s40265-017-0704-6

10-01-2016 | Retinopathy | Review | Article

Fenofibrate and diabetic retinopathy

Knickelbein JE, Abbott AB, Chew EY. Curr Diab Rep 2016; 16: 90. doi: 10.1007/s11892-016-0786-7

12-01-2015 | Retinopathy | Review | Article

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss

Lee R et al. Eye and Vis 2015; 2: 17. doi: 10.1186/s40662-015-0026-2

image credits